Subscribers
Non-subscribers
- Purchase article PDF [£30 + taxes]
- Purchase article PDF member offer [£5 + taxes]
Free access
Communication
Lab Chip, 2010, 10, 27 - 29, DOI: 10.1039/b917959c
Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody
Jason P. Gleghorn, Erica D. Pratt, Denise Denning, He Liu, Neil H. Bander, Scott T. Tagawa, David M. Nanus, Paraskevi A. Giannakakou and Brian J. Kirby
Geometrically enhanced differential immunocapture (GEDI) and an antibody for prostate-specific membrane antigen (PSMA) are used for high-efficiency and high-purity capture of prostate circulating tumor cells from peripheral whole blood samples of castrate-resistant prostate cancer patients.

